Skip to main content

8 Result(s)

within **-Hyuk Kwon Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study

    Thromboembolic events (TEEs) are significant adverse events that can cause serious morbidities and mortality in cancer patients receiving chemotherapy. Patients with gastric cancer (GC) treated with palliative...

    Tae-Hwan Kim, **-Hyuk Choi, Sang Min Jeon, Yong Won Choi, Minsuk Kwon… in Gastric Cancer (2023)

  2. No Access

    Article

    A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis

    ST2 functions as a receptor for the cytokine IL-33. It has been implicated in carcinogenesis. In this study, we sought to mechanistically determine how ST2 and IL-33 function to support cancer stem cell (CSC) ...

    Jong-Wan Kwon, Sang-Hyuk Seok, Somi Kim, Hyeok-Won An, Anahita Dev Choudhury… in Oncogene (2023)

  3. No Access

    Article

    Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer

    Gene mutations play critical roles during cancer development and progression, and therefore represent targets for precision medicine. Here we recapitulated the pharmacogenomic data to delineate novel candidate...

    Sarah Yoon, Eun-Ju Lee, Ji-Hye Choi, Taek Chung, Do Young Kim, Jong-Yeop Im… in Oncogene (2018)

  4. No Access

    Article

    Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting

    The role of adjuvant chemotherapy (AC) after radical cystectomy for bladder cancer remains unclear. This study evaluated the benefits of cisplatin-based AC plus surgery versus surgery alone in patients with bl...

    Taekmin Kwon, In Gab Jeong, JungBok Lee… in Journal of Cancer Research and Clinical On… (2015)

  5. No Access

    Article

    Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer

    To determine the efficacy and tolerance of irinotecan in combination with S-1 (IRIS) for patients whose disease progressed after treatment with an oxaliplatin-based therapy for colorectal cancer (CRC). Each pa...

    Sung Yong Oh, Young-Tae Ju, Sang-Kyung Choi, Chang Yoon Ha… in Investigational New Drugs (2011)

  6. No Access

    Article

    Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases

    Certain patients may be unwilling to accept blood products for religious reasons. In this study, we have assessed the clinical cancer treatment outcomes of Jehovah’s Witnesses (JW) cancer patients in order to ...

    Sung Yong Oh, Sung-Hyun Kim, Hyuk-Chan Kwon, Suee Lee… in Supportive Care in Cancer (2010)

  7. No Access

    Article

    ACNU–cisplatin Continuous Infusion Chemotherapy as Salvage Therapy for Recurrent Glioblastomas: Phase II Study

    Purpose: To evaluate the activity and the toxicity of ACNU (1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-cholroethyl)-3-nitrosourea hydrochloride) administered with cisplatin by intravenous infusion for 72 h in...

    Ho-Shin Gwak, Sang-Min Youn, Austin-Hyuk Kwon, Seung Hoon Lee… in Journal of Neuro-Oncology (2005)

  8. No Access

    Article

    Gene Expression Profiling in Lymph Node-Positive and Lymph Node-Negative Colorectal Cancer

    PURPOSE: To identify the genes involved in the carcinogenesis and progression of colorectal cancer, we analyzed the gene-expression profiles of colorectal cancer cells from 12 tumors with corresponding noncanc...

    Hyuk-Chan Kwon M.D., Ph.D., Sung-Hyun Kim M.D.… in Diseases of the Colon & Rectum (2004)